Trial · NCT04699383
Documentation of Patient Outcomes for SSG/Allopurinol Combination Treatment in Ethiopia
NCT04699383, Completed, Institute of Tropical Medicine, Belgium
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Documentation of Patient Outcomes for SSG/Allopurinol Combination Treatment in Ethiopia. Trials, record NCT04699383. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04699383
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Documentation of Patient Outcomes for SSG/Allopurinol Combination Treatment in Ethiopia
- NCT number
- NCT04699383
- Status
- Completed
- Enrollment
- 105 participants, actual
- Lead sponsor
- Institute of Tropical Medicine, Belgium
- Conditions
- Cutaneous Leishmaniasis
- Interventions
- Sodium Stibogluconate with allopurinol
- First posted
- 2021-01-07
- Last updated
- 2024-03-18
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Treatment outcome at day 180 (proportion with cure, good response, poor response, no response and relapse) | day 180 | cure defined as 100% flattening and/or reepithelization, good response 50-99% flattening and/or reepithelization, poor response 1-49% flattening and/or reepithelization, no response 0% flattening and/or reepithelization and relapse as worsening of existing lesion or appearance of new lesions |
| Secondary | Patient reported outcomes using the dermatology life quality index (DLQI) | day 0 - day 180 | Mean difference in Dermatology life quality index (min 0, max 30) before treatment and at day 180 |
| Secondary | Side-effects | day 0 - day 180 | Proportion of patients with side-effects and proportion of side-effects according to CTCAE severity grades |
| Secondary | Cycles to cure | day 0 - day 180 | Number of cycles needed to reach cure |
| Secondary | Factors associated with cure | day 30, day 180 | To determine covariate-adjusted risk ratios for baseline and follow-up factors associated with cure after one cycle of treatment and at the end of cycle 5 |
| Secondary | Treatment outcome at day 30 (proportion with cure, good response, poor response, and no response ) | day 30 | cure defined as 100% flattening and/or reepithelization, good response 50-99% flattening and/or reepithelization, poor response 1-49% flattening and/or reepithelization, no response 0% flattening and/or reepithelization |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 37624352 | RESULT |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04699383
GET https://conductscience.org/api/trials/v1/NCT04699383/registered